<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8804207</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1862</journal-id>
<journal-id journal-id-type="nlm-ta">Schizophr Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Schizophr. Res.</journal-id>
<journal-title-group>
<journal-title>Schizophrenia research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0920-9964</issn>
<issn pub-type="epub">1573-2509</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28202290</article-id>
<article-id pub-id-type="pmc">5554466</article-id>
<article-id pub-id-type="doi">10.1016/j.schres.2017.02.001</article-id>
<article-id pub-id-type="manuscript">NIHMS852276</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of psychotropic drug treatment on sterol metabolism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Korade</surname>
<given-names>Å½eljka</given-names>
</name>
<xref ref-type="aff" rid="A1">(1)</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="A2">(2)</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Warren</surname>
<given-names>Emily B.</given-names>
</name>
<xref ref-type="aff" rid="A3">(3)</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Armstrong</surname>
<given-names>Kristan</given-names>
</name>
<xref ref-type="aff" rid="A4">(4)</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Porter</surname>
<given-names>Ned A.</given-names>
</name>
<xref ref-type="aff" rid="A2">(2)</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Konradi</surname>
<given-names>Christine</given-names>
</name>
<xref ref-type="aff" rid="A3">(3)</xref>
<xref ref-type="aff" rid="A4">(4)</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>(1)</label>Department of Pediatrics and Department of Biochemistry and Molecular Biology, UNMC, Omaha, NE 68198</aff>
<aff id="A2">
<label>(2)</label>Department of Chemistry and Vanderbilt Institute of Chemical Biology, Nashville, TN 37235</aff>
<aff id="A3">
<label>(3)</label>Department of Pharmacology, Vanderbilt University, Nashville TN, 37240</aff>
<aff id="A4">
<label>(4)</label>Department of Psychiatry, Vanderbilt University, Nashville, TN 37212</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Christine Konradi, Ph.D., Professor, Vanderbilt University, PMB 407933, MRB3, Suite 8160, 465 21st Avenue South, Nashville, TN 37240-7933, 615-936-1021, <email>Christine.konradi@vanderbilt.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Conflict of interest disclosure:</bold>
</p>
<p>The authors declare no conflict of interest</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>187</volume>
<fpage>74</fpage>
<lpage>81</lpage>
<!--elocation-id from pubmed: 10.1016/j.schres.2017.02.001-->
<abstract>
<p id="P2">Cholesterol metabolism is vital for brain function. Previous work in cultured cells has shown that a number of psychotropic drugs inhibit the activity of 7-dehydrocholesterol reductase (DHCR7), an enzyme that catalyzes the final steps in cholesterol biosynthesis. This leads to the accumulation of 7-dehydrocholesterol (7DHC), a molecule that gives rise to oxysterols, vitamin D, and atypical neurosteroids. We examined levels of cholesterol and the cholesterol precursors desmosterol, lanosterol, 7DHC and its isomer 8-dehydrocholesterol (8DHC), in blood samples of 123 psychiatric patients on various antipsychotic and antidepressant drugs, and 85 healthy controls, to see if the observations in cell lines hold true for patients as well. Three drugs, aripiprazole, haloperidol and trazodone increased circulating 7DHC and 8DHC levels, while five other drugs, clozapine, escitalopram/citalopram, lamotrigine, olanzapine, and risperidone, did not. Studies in rat brain verified that haloperidol dose-dependently increased 7DHC and 8DHC levels, while clozapine had no effect. We conclude that further studies should investigate the role of 7DHC and 8DHC metabolites, such as oxysterols, vitamin D, and atypical neurosteroids, in the deleterious and therapeutic effects of psychotropic drugs. Finally, we recommend that drugs that increase 7DHC levels should not be prescribed during pregnancy, as children born with DHCR7 deficiency have multiple congenital malformations.</p>
</abstract>
<kwd-group>
<kwd>cholesterol</kwd>
<kwd>haloperidol</kwd>
<kwd>clozapine</kwd>
<kwd>aripiprazole</kwd>
<kwd>trazodone</kwd>
<kwd>neurosteroids</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>